S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

GRIFOLS S A/S News Headlines (NASDAQ:GRFS)

$24.41
-0.09 (-0.37 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$24.30
Now: $24.41
$24.58
50-Day Range
$22.64
MA: $23.91
$25.63
52-Week Range
$17.57
Now: $24.41
$25.73
Volume1.28 million shs
Average Volume996,435 shs
Market Capitalization$16.78 billion
P/E Ratio27.12
Dividend Yield1.39%
Beta1.08

Headlines

GRIFOLS S A/S (NASDAQ GRFS) News Headlines

Source:
DateHeadline
GRIFOLS S A/S (NASDAQ:GRFS) Receives Consensus Rating of "Buy" from AnalystsGRIFOLS S A/S (NASDAQ:GRFS) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - February 24 at 3:52 AM
Comparing GRIFOLS S A/S (NASDAQ:GRFS) and Adamas Pharmaceuticals (NASDAQ:ADMS)Comparing GRIFOLS S A/S (NASDAQ:GRFS) and Adamas Pharmaceuticals (NASDAQ:ADMS)
www.americanbankingnews.com - February 23 at 7:34 AM
Can You Imagine How Grifolss (BME:GRF) Shareholders Feel About The 85% Share Price Increase?Can You Imagine How Grifols's (BME:GRF) Shareholders Feel About The 85% Share Price Increase?
finance.yahoo.com - February 21 at 2:55 PM
Can You Imagine How Grifols's (BME:GRF) Shareholders Feel About The 85% Share Price Increase?Can You Imagine How Grifols's (BME:GRF) Shareholders Feel About The 85% Share Price Increase?
finance.yahoo.com - February 21 at 8:13 AM
Grifols to Help Saudi Arabia Produce Blood Plasma MedicinesGrifols to Help Saudi Arabia Produce Blood Plasma Medicines
www.nytimes.com - February 18 at 1:43 PM
Grifols, S.A. American Depositary Shares (GRFS) Institutional HoldingsGrifols, S.A. American Depositary Shares (GRFS) Institutional Holdings
www.nasdaq.com - February 16 at 11:05 PM
GRIFOLS S A/S (NASDAQ:GRFS) Short Interest UpdateGRIFOLS S A/S (NASDAQ:GRFS) Short Interest Update
www.americanbankingnews.com - February 11 at 10:58 PM
Family Builds $3.8 Billion Fortune, One Pint of Blood at a TimeFamily Builds $3.8 Billion Fortune, One Pint of Blood at a Time
finance.yahoo.com - February 10 at 8:49 AM
Human Rabies Immunoglobulin (IM) Market Strategies and Insight Driven Transformation (2020-2029) | CSL Behring, Grifols, SanofiHuman Rabies Immunoglobulin (IM) Market Strategies and Insight Driven Transformation (2020-2029) | CSL Behring, Grifols, Sanofi
www.marketwatch.com - January 31 at 7:22 AM
Need To Know: Grifols, S.A. (BME:GRF) Insiders Have Been Buying SharesNeed To Know: Grifols, S.A. (BME:GRF) Insiders Have Been Buying Shares
finance.yahoo.com - January 7 at 2:35 AM
Grifols says trial shows positive effects in slowing AlzheimersGrifols says trial shows positive effects in slowing Alzheimer's
www.reuters.com - December 6 at 6:00 PM
Grifols presents its latest Alzheimers clinical trial dataGrifols presents its latest Alzheimer's clinical trial data
www.prnewswire.com - December 6 at 6:00 PM
Grifols presents its latest Alzheimer's clinical trial dataGrifols presents its latest Alzheimer's clinical trial data
finance.yahoo.com - December 6 at 6:00 PM
Is Grifols (BME:GRF) A Risky Investment?Is Grifols (BME:GRF) A Risky Investment?
finance.yahoo.com - November 19 at 9:42 AM
Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPDGrifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD
finance.yahoo.com - November 7 at 1:15 PM
Grifols, S.A. American Depositary Shares (GRFS) Earnings Report DateGrifols, S.A. American Depositary Shares (GRFS) Earnings Report Date
www.nasdaq.com - November 3 at 11:00 PM
Is Grifols, S.A.'s (BME:GRF) ROE Of 12% Impressive?Is Grifols, S.A.'s (BME:GRF) ROE Of 12% Impressive?
finance.yahoo.com - October 14 at 3:19 AM
Hedge Funds Have Never Been This Bullish On Grifols SA (GRFS)Hedge Funds Have Never Been This Bullish On Grifols SA (GRFS)
finance.yahoo.com - October 11 at 1:16 PM
Is Grifols, S.A. (BME:GRF) Worth €27.10 Based On Its Intrinsic Value?Is Grifols, S.A. (BME:GRF) Worth €27.10 Based On Its Intrinsic Value?
finance.yahoo.com - September 18 at 2:15 AM
Grifols SA, Barcelona is Now Oversold (GRFS)Grifols SA, Barcelona is Now Oversold (GRFS)
www.nasdaq.com - September 10 at 9:28 AM
Should Grifols (BME:GRF) Be Disappointed With Their 61% Profit?Should Grifols (BME:GRF) Be Disappointed With Their 61% Profit?
finance.yahoo.com - August 23 at 8:40 AM
Is Grifols, S.A.'s (BME:GRF) 1.2% Dividend Worth Your Time?Is Grifols, S.A.'s (BME:GRF) 1.2% Dividend Worth Your Time?
finance.yahoo.com - July 31 at 6:45 AM
Prothrombin Complex Concentrate (PCC) Market boosted at Impressive 9.1% CAGR propelled by Increasing Government Funding for Clinical Studies, says Fortune Business InsightsProthrombin Complex Concentrate (PCC) Market boosted at Impressive 9.1% CAGR propelled by Increasing Government Funding for Clinical Studies, says Fortune Business Insights
feeds.benzinga.com - July 11 at 12:15 PM
How Much Are Grifols, S.A. (BME:GRF) Insiders Spending On Buying Shares?How Much Are Grifols, S.A. (BME:GRF) Insiders Spending On Buying Shares?
finance.yahoo.com - July 8 at 9:02 AM
This Pharma Stock Dodged A Broad Slide For Drugmakers — Here's WhyThis Pharma Stock Dodged A Broad Slide For Drugmakers — Here's Why
finance.yahoo.com - July 5 at 5:43 PM
Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in AfricaGrifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa
finance.yahoo.com - July 3 at 9:08 AM
Is Grifols SA (GRFS) A Good Stock To Buy ?Is Grifols SA (GRFS) A Good Stock To Buy ?
finance.yahoo.com - June 30 at 8:55 AM
Do Institutions Own Grifols, S.A. (BME:GRF) Shares?Do Institutions Own Grifols, S.A. (BME:GRF) Shares?
finance.yahoo.com - June 6 at 9:07 AM
Grifols Announces PharmacyKeeper Bidirectional Integration with EpicGrifols Announces PharmacyKeeper Bidirectional Integration with Epic
finance.yahoo.com - April 30 at 8:57 AM
What Does Grifols, S.A.'s (BME:GRF) P/E Ratio Tell You?What Does Grifols, S.A.'s (BME:GRF) P/E Ratio Tell You?
finance.yahoo.com - April 29 at 8:56 AM
Grifols US donor centers exceed 250,000 pounds of food collectedGrifols US donor centers exceed 250,000 pounds of food collected
finance.yahoo.com - April 18 at 9:06 AM
Grifols, S.A. (BME:GRF): What We Can Expect From This Growth StockGrifols, S.A. (BME:GRF): What We Can Expect From This Growth Stock
finance.yahoo.com - April 2 at 10:05 AM
Should You Buy Grifols SA (GRFS)?Should You Buy Grifols SA (GRFS)?
finance.yahoo.com - March 31 at 6:24 PM
Grifols Announces the Opening of its new Plasma Donor Center in Russellville, ARGrifols Announces the Opening of its new Plasma Donor Center in Russellville, AR
finance.yahoo.com - March 23 at 9:25 AM
Blood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAASBlood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAAS
finance.yahoo.com - March 7 at 9:29 AM
Spains Grifols, Chinas Shanghai RAAS form strategic allianceSpain's Grifols, China's Shanghai RAAS form strategic alliance
finance.yahoo.com - March 7 at 9:29 AM
Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call TranscriptRigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - March 1 at 9:30 AM
Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive YearGrifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year
finance.yahoo.com - February 21 at 5:55 PM
East Bay biotech with late-stage drug files for bankruptcyEast Bay biotech with late-stage drug files for bankruptcy
finance.yahoo.com - February 19 at 6:21 PM
'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner
finance.yahoo.com - February 19 at 6:21 PM
What To Know Before Buying Grifols, S.A. (BME:GRF) For Its DividendWhat To Know Before Buying Grifols, S.A. (BME:GRF) For Its Dividend
finance.yahoo.com - February 5 at 11:12 AM
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in EuropeRigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
www.bizjournals.com - January 23 at 8:54 AM
Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutionsGrifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions
finance.yahoo.com - January 8 at 9:03 AM
A Note On Grifols, S.A.’s (BME:GRF) ROE and Debt To EquityA Note On Grifols, S.A.’s (BME:GRF) ROE and Debt To Equity
finance.yahoo.com - January 6 at 8:54 AM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel